TITLE

Neurogenic detrusor overactivity in adults: a review on efficacy, tolerability and safety of oral antimuscarinics

AUTHOR(S)
Madersbacher, H; Mürtz, G; Stöhrer, M
PUB. DATE
June 2013
SOURCE
Spinal Cord;Jun2013, Vol. 51 Issue 6, p432
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objectives:This review analyzed efficacy, tolerability and safety of oral antimuscarinic (AM) drugs in adults suffering from neurogenic detrusor overactivity (NDO).Methods:A comprehensive search of major literature bases was conducted to identify all references.Results:Thirty studies, thereof 16 randomized controlled trials (RCT), enrolling 1479 patients were identified and included in the review. Results were grouped in dose-finding, placebo- and active-controlled, flexible dose and combined high-dose AM drugs, and various studies. Key urodynamic outcome parameters, such as maximum detrusor pressure and maximum cystometric bladder capacity, demonstrated the efficacy of AM in NDO, following 2-3 weeks of treatment. Contrary to idiopathic detrusor overactivity (IDO), no placebo effects manifested. Other important parameters, such as impact on the upper urinary tract function and morphology, issues of continence, post-void residual urine, catheterisation, urinary tract infections and quality of life, were investigated to a limited extent only. Incidence rates of adverse events were comparable for NDO and IDO. Most of the studies, especially RCT, were undertaken with oxybutynin immediate release (IR), trospium chloride IR, propiverine IR and propiverine extended release. In NDO, these drugs are best investigated.Conclusions:AM drugs are effective in NDO, they normalize the intravesical pressure and increase cystometric bladder capacity. However, other important parameters are not adequately investigated so far and should be recognized in future studies.
ACCESSION #
88041493

 

Related Articles

  • Clinical Use of Tolterodine Extended Release in Overactive Bladder. El Yazami Adli, Oussama; Corcos, Jacques // Clinical Medicine Insights: Urology;2012, Issue 6, p1 

    Overactive bladder (OAB) is a common problem whose prevalence increases with advancing age and compromises health- related quality of life. Tolterodine was the first antimuscarinic drug specifically designed to treat OAB. Through MEDLINE, we reviewed articles, standardization reports and meeting...

  • Antimuscarinic Treatment in Overactive Bladder. Wagg, Adrian S. // Drugs & Aging;2012, Vol. 29 Issue 7, p539 

    Overactive bladder is a common condition that increases in prevalence in association with age. Antimuscarinic therapy remains the mainstay of pharmacological treatment for the condition, and there is an increasing body of evidence that supports the use of these drugs. Despite this, and because...

  • Antimuscarinic drugs to treat overactive bladder. Robinson, Dudley; Cardozo, Linda // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;4/14/2012, Vol. 344 Issue 7852, p43 

    The article discusses the treatment for Overactive bladder by antimuscarinic drugs, a term used to describe the symptom complex of urinary urgency, usually accompanied by frequency and nocturia, with or without urge urinary incontinence, in the absence of urinary tract infection or other obvious...

  • Avoid antimuscarinic drugs in people with dementia. Braithwaite, Rich // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;5/12/2012, Vol. 344 Issue 7856, p30 

    A letter to the editor is presented in response to the article "Antimuscarinic drugs to treat overactive bladder" by Robinson D, and colleague in the 2012 issue.

  • The effects of verbal instructions on gait in people with Parkinson's disease: a systematic review of randomized and non-randomized trials. Fok, Pamela; Farrell, Michael; McMeeken, Joan; Kuo, Yi-Liang // Clinical Rehabilitation;May2011, Vol. 25 Issue 5, p396 

    Objective: To collate and appraise empirical evidence relating to the effects of verbal instructions (verbal commands given by another person) on stride length, gait velocity and stride variability in people with Parkinson’s disease.Data sources: Cinahl, Cochrane, Embase, Medline, PEDro,...

  • A systematic review and synthesis of the quantitative and qualitative evidence behind patient-centred goal setting in stroke rehabilitation. Rosewilliam, Sheeba; Roskell, Carolyn Anne; Pandyan, AD // Clinical Rehabilitation;Jun2011, Vol. 25 Issue 6, p501 

    Objective: To map out from the literature the nature, extent and effects of application of patient-centred goal setting in stroke rehabilitation practice.Design: Systematic review.Data sources: A search was conducted in the Cochrane (Wiley), AMED, Medline (EBSCO), Embase, Sports discuss, Medline...

  • Daily physical activity of patients with the chronic fatigue syndrome: a systematic review. Evering, Richard MH; van Weering, Marit GH; Groothuis-Oudshoorn, Karin CGM; Vollenbroek-Hutten, Miriam MR // Clinical Rehabilitation;Feb2011, Vol. 25 Issue 2, p112 

    Objective: To give an overview of the physical activity level of patients with chronic fatigue syndrome in comparison with asymptomatic controls.Data sources: MEDLINE, Web of Science, EMBASE, PsycINFO, Picarta, the Cochrane Controlled Trial Register that is included in the Cochrane Library and...

  • Non-Hormonal treatment of BPH/BOO. Osman, Nadir I.; Mangera, Altaf; Chapple, Christopher R. // Indian Journal of Urology;Apr-Jun2014, Vol. 30 Issue 2, p194 

    Objectives: To review the use of non-hormonal pharmacotherapies in the treatment of lower urinary tract symptoms (LUTS) due to presumed benign prostatic hyperplasia (BPH). Materials and Methods: A search of the PUBMED database was conducted for the terms BPH, LUTS, bladder outlet Materials and...

  • Efficacy and Safety of Botulinum Toxin A Intradetrusor Injections in Adults with Neurogenic Detrusor Overactivity/Neurogenic Overactive Bladder: A Systematic Review. Soljanik, Irina // Drugs;2013, Vol. 73 Issue 10, p1055 

    Background: Botulinum toxin A (BoNTA) is increasingly used for therapy of neurogenic detrusor overactivity (NDO) refractory to antimuscarinics or where patients are experiencing antimuscarinic-related side effects. Objective: The objective was to compare and critically discuss the reported...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics